Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999
New Onset Weakness in the Face and Arm
BMJ 368:L7077, Brites, L.,et al, 2020
MR Target Sign in Cerebral Aspergillosis
Neurohospitalist doi:10.1177/1941874420929191, Finelli, P.F., 2020
Progressive Multifocal Leukoencephalopathy in a Patient with Primary Amyloid Light-Chain Amyloidosis
Clin Neurol Neurosurg 192:doi105709, Katsuse, K.,et al, 2020
Clinicopathologic Conference, Cushings syndrome due to a well-differentiated, low-grade thymic neuroendocrine tumor with corticotropin
NEJM 378:2322-2332, Case 18-2018, 2018
Viral Infections of the Nervous System, Chronic Meningitis, and Prior Diseases, IFe Acquired Immunodeficiency Syndrome
Adams & Victors Principles of Neurology, Chp 33, pg 758, Ropper, A.H.,et al, 2014
Clinicopath Conf, Acute HIV-1 Infection
NEJM 360:1540-1548, Case 11-2009, 2009
The Neurologic Manifestations of Systemic Lupus Erythematosus
The Neurologist 15:115-121, Greenberg,B.M., 2009
A Rash, Circulating Anticoagulant, Then Meningitis
Lancet 351:1856, Schanen,A.,et al, 1998
Hematologic Manifestations of AIDS
In Hematology-Basic Principles & Practice, Churchill Liningstone, NY Ch 155, p2171., Hoxie,J.A., 1995
HIV-Negative"AIDS"in Kentucky:A Case of Idiopathic CD4+Lymphopenia and Cryptococcal Meningitis
South Med J 87:751-752, Ramirez,J.A.,et al, 1994
Interferon Beta-1b is Effective in Relapsing-Remitting MS
Clinical Results of a Placebo-Controlled Trial, IFNB MS Study Grp, Neurol 43:655-661, 64193., , 1993